350 related articles for article (PubMed ID: 25180260)
1. The gut-adipose-liver axis in the metabolic syndrome.
Konrad D; Wueest S
Physiology (Bethesda); 2014 Sep; 29(5):304-13. PubMed ID: 25180260
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
3. Managing the manager: gut microbes, stem cells and metabolism.
Serino M; Blasco-Baque V; Nicolas S; Burcelin R
Diabetes Metab; 2014 Jun; 40(3):186-90. PubMed ID: 24462190
[TBL] [Abstract][Full Text] [Related]
4. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
Diamant M; Blaak EE; de Vos WM
Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue.
Cani PD
Clin Microbiol Infect; 2012 Jul; 18 Suppl 4():50-3. PubMed ID: 22647050
[TBL] [Abstract][Full Text] [Related]
6. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
[TBL] [Abstract][Full Text] [Related]
7. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH.
Anty R; Bekri S; Luciani N; Saint-Paul MC; Dahman M; Iannelli A; Amor IB; Staccini-Myx A; Huet PM; Gugenheim J; Sadoul JL; Le Marchand-Brustel Y; Tran A; Gual P
Am J Gastroenterol; 2006 Aug; 101(8):1824-33. PubMed ID: 16790033
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, adipose depots and gut: interactions and pathological implications.
Gastaldelli A; Natali A; Vettor R; Corradini SG
Dig Liver Dis; 2010 May; 42(5):310-9. PubMed ID: 20194050
[TBL] [Abstract][Full Text] [Related]
9. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
Wisse BE
J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
[TBL] [Abstract][Full Text] [Related]
10. Advances in adipokines.
Sahin-Efe A; Katsikeris F; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1659-65. PubMed ID: 23021039
[No Abstract] [Full Text] [Related]
11. Obesity: a complex growing challenge.
Pataky Z; Bobbioni-Harsch E; Golay A
Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):427-33. PubMed ID: 19856250
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue macrophages.
Zeyda M; Stulnig TM
Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity.
Samad F; Badeanlou L; Shah C; Yang G
Adv Exp Med Biol; 2011; 721():67-86. PubMed ID: 21910083
[TBL] [Abstract][Full Text] [Related]
14. Metabolic inflammation: connecting obesity and insulin resistance.
Dali-Youcef N; Mecili M; Ricci R; Andrès E
Ann Med; 2013 May; 45(3):242-53. PubMed ID: 22834949
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
[TBL] [Abstract][Full Text] [Related]
16. [Obesity--insulin resistance--type 2 diabetes mellitus].
Małecki MT
Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S561-6. PubMed ID: 20527377
[TBL] [Abstract][Full Text] [Related]
17. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
Klein S; Fontana L; Young VL; Coggan AR; Kilo C; Patterson BW; Mohammed BS
N Engl J Med; 2004 Jun; 350(25):2549-57. PubMed ID: 15201411
[TBL] [Abstract][Full Text] [Related]
18. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
19. Metabolic complications of obesity: inflated or inflamed?
Chandalia M; Abate N
J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Esteve E; Ricart W; Fernández-Real JM
Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
